Single Cell Analysis Market is Expected to Grow with a CAGR of 15.1% from 2022 to 2028

As stated in our extensive report, theGlobalSingle Cell Analysis Marketaccounted forUSD 2.57 Billionin 2021.

Single-cell analysis helps to understand the working of cell networks in concert to coordinate a response at the population level. The single-cell analysis also helps in obtaining information about cellular functionality. This type of analysis needs insight into different cellular components that include DNA, RNA, and protein content, as well the metabolites like pigments. There are various types of cells, each having a different lineage and 160; Cells can be similar from a morphological and genetic point of view but are heterogeneous. These differences might have a significant impact on the health and function of the population. Single-cell isolation needs several approaches such as laser-capture microdissection, micromanipulation, and fluorescence-activated cell sorting, along with the introduction of a number of novel techniques to isolate single cells with greater accuracy and specificity. The single-cell analysis also allows the learning of cell-to-cell differentiation among a cell population.

The technological advancements in single-cell analysis products along with the rising prevalence of cancer are anticipated to augment the growth of the Single Cell Analysis Market during the forecast period. Cancer is a major reason for death worldwide; nearly 10 million deaths were estimated by World Health Organization in 2020. Maximum new cases of cancer were breast cancer cases followed by lung, colon, and rectum. This is attributable to the increasing tobacco use, rise in alcohol consumption, unhealthy diet, physical inactivity, and increasing air pollution. In order to study and learn drug development, in-depth analysis of cancer, stem cell differentiation, physiological functions in adults as well as embryos can only be achieved with single-cell analysis. Hence, the increased cancer rates and other diseases have increased the need for single-cell analysis. Furthermore, increasing Research and Development (R&D) in the pharmaceutical & biotechnology industries for complex diseases coupled with growth in stem cell research and growing focus on personalized medicine is also expected to augment the growth of the market in near future.

However, the high cost of single-cell analysis products is expected to hamper the growth of Single Cell Analysis Market in the years to come. Moreover, the high growth potential of single-cell sequencing and integration of microfluidics in the single-cell analysis along with emerging Asian markets is further anticipated to create more opportunities for the growth of the Single Cell Analysis technology within the estimated 10;Additionally, various companies are focusing on investing a significant amount in the development of solutions which is also expected to support the growth of the market.

North America held the largest share in the Global Single Cell Analysis Market and is likely to continue the same trend during the forecast period. The U.S. dominated in the North America region. This is attributable to the rising personal healthcare expenditure and high government funding in the region. Additionally, the growing awareness amongst consumers along with the speedy adoption of novel analytical techniques is also expected to support the growth of the market in near 10;Asia Pacific is expected to grow at a considerable CAGR during the forecast period. This is attributable to the rapidly developing healthcare infrastructure and rise in the medical tourism industry coupled with increasing demand for advanced diagnostic tools from emerging economies like India and China in the region.

Some of the prominent players operating in the GlobalSingle Cell Analysis Market include Bio-Rad Laboratories Inc. (US), Illumina Inc. (US), Beckman Coulter Inc. (US), Danaher Corporation (US), Becton (US), Dickinson and Company (US), Fluidigm Corporation (US)..